{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-030244","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.426024+00:00","generated_at":"2026-06-01T01:06:49.757285+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GRI Bio prices $4.0M public offering of shares and warrants at $1.83/unit","bullets":["Offering of 2,185,793 shares (or equivalents) plus Series C-1 and C-2 warrants at $1.83 per unit.","Gross proceeds ~$4.0M, net proceeds ~$3.2M after 7% placement agent fee and expenses.","Warrants exercisable at $1.83/share upon stockholder approval; C-1 expires 5 yrs, C-2 expires 18 months.","Proceeds allocated to product candidate development, working capital, and general corporate purposes.","H.C. Wainwright is exclusive placement agent; closing expected on or about June 28, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-030244","json":"https://secwatch.observer/filing/0001628280-24-030244.json","markdown":"https://secwatch.observer/filing/0001628280-24-030244.md","text":"https://secwatch.observer/filing/0001628280-24-030244.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000162828024030244/0001628280-24-030244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000162828024030244/val-20240626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:06:49.757285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}